Mead Johnson Nutrition CO  

(Public, NYSE:MJN)   Watch this stock  
Find more results for MJN
+0.72 (0.74%)
May 21 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 96.77 - 97.99
52 week 85.61 - 105.45
Open 97.24
Vol / Avg. 0.00/1.46M
Mkt cap 19.65B
P/E 27.40
Div/yield 0.41/1.69
EPS 3.57
Shares 202.60M
Beta 0.72
Inst. own 96%
Jul 23, 2015
Q2 2015 Mead Johnson Nutrition Co Earnings Release - 9:30AM EDT - Add to calendar
Jul 23, 2015
Q2 2015 Mead Johnson Nutrition Co Earnings Call Add to calendar
Jun 9, 2015
Mead Johnson Nutrition Co at Deutsche dbAccess Global Consumer Conference Add to calendar
May 28, 2015
Mead Johnson Nutrition Co at Citi Global Consumer Conference - 12:00PM EDT - Add to calendar
Apr 30, 2015
Mead Johnson Nutrition Co Annual Shareholders Meeting
Apr 23, 2015
Q1 2015 Mead Johnson Nutrition Co Earnings Call - Webcast
Apr 23, 2015
Q1 2015 Mead Johnson Nutrition Co Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 18.92% 16.53%
Operating margin 26.06% 22.41%
EBITD margin - 24.28%
Return on average assets 21.69% 20.10%
Return on average equity 133.72% 165.92%
Employees 7,700 -
CDP Score - 92 B


2701 Patriot Blvd Fl 4
GLENVIEW, IL 60026-8039
United States - Map
+1-847-8322420 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Mead Johnson Nutrition Company (Mead Johnson) is a global pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children's nutrition and other nutritional products. Its Enfa family of brands, including Enfamil infant formula, is the global brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers, health care professionals and retailers in more than 50 countries in Asia, North America, Latin America and Europe. In addition to the Enfa family of brands, the Company markets several other brands on a local, regional or global basis. These brands complement the Enfa family of brands portfolio, such as Nutramigen or the nutritional needs of broad consumer populations, such as ChocoMilk and Cal-C-Tose.

Officers and directors

Peter Kasper Jakobsen President, Chief Executive Officer, Director
Age: 52
Bio & Compensation  - Reuters
Charles M. Urbain Interim Chief Financial Officer
Age: 60
Bio & Compensation  - Reuters
Patrick M. Sheller Senior Vice President, General Counsel, Secretary
Age: 53
Bio & Compensation  - Reuters
James Jeffrey Jobe Senior Vice President - Technical Operations
Age: 55
Bio & Compensation  - Reuters
Dirk Hondmann Ph.D. Chief Scientific Officer
Age: 51
Bio & Compensation  - Reuters
Tom De Weerdt Vice President, Corporate Controller
Age: 42
Bio & Compensation  - Reuters
James M. Cornelius Non-Executive Chairman of the Board
Age: 71
Bio & Compensation  - Reuters
Stephen W. Golsby Director
Age: 60
Bio & Compensation  - Reuters
Elliott Sigal M.D., Ph.D. Director
Age: 63
Bio & Compensation  - Reuters
Steven M. Altschuler M.D. Independent Director
Age: 61
Bio & Compensation  - Reuters